InVivo Therapeutics to Present at the LD Micro Main Event on Tuesday December 4th, 2018
November 29 2018 - 8:00AM
Business Wire
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today
announced that Richard Toselli, M.D., President and Chief Executive
Officer, will present at the LD Micro Main Event on Tuesday,
December 4, 2018 at 7:30 am Pacific Time at the Luxe Hotel in Los
Angeles, CA . Dr. Toselli’s presentation will discuss recent
company updates. A live webcast of Dr. Toselli’s presentation will
be available at http://wsw.com/webcast/ldmicro15/nviv/ and a
webcast replay will be available at the same address approximately
one hour after the live webcast presentation. Please log in 5-10
minutes before the event to ensure a timely connection. Dr. Toselli
will also be available for one-on-one meetings at the
conference.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a research and
clinical-stage biomaterials and biotechnology company with a focus
on treatment of spinal cord injuries. The company was founded in
2005 with proprietary technology co-invented by Robert Langer,
Sc.D., Professor at Massachusetts Institute of Technology, and
Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital
and who now is affiliated with Massachusetts General Hospital. In
January 2018, the company announced updated clinical evidence,
including improvements in patients with acute spinal cord injury
(SCI), from its INSPIRE study of the Neuro-Spinal Scaffold™. The
publicly traded company is headquartered in Cambridge, MA. For more
details, visit www.invivotherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181129005067/en/
Heather Hamel(617) 863-5530Investor
RelationsInvestor-relations@invivotherapeutics.com
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Aug 2024 to Sep 2024
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Sep 2023 to Sep 2024